Uveiit

Uveiit is not a recognized medical term. In contemporary ophthalmology, inflammation of the uveal tract is called uveitis. The spelling “uveiit” may be a misspelling, typographical error, or informal variant encountered in nonstandard sources. The correct terminology emphasizes the same underlying condition.

Uveitis refers to inflammation that can affect different parts of the uvea—the iris, ciliary body, and choroid. Anterior uveitis (iritis or iridocyclitis) is the most common form; intermediate, posterior, and panuveitis involve deeper or broader regions of the uveal tract. Symptoms typically include eye pain, redness, sensitivity to light, blurred vision, and floaters. The onset can be sudden or gradual and may affect one or both eyes.

Causes are diverse and may be infectious (such as toxoplasmosis or herpes viruses) or non-infectious, often related to autoimmune or systemic inflammatory diseases (for example HLA-B27-associated conditions, sarcoidosis, or inflammatory bowel disease). In many cases the cause remains idiopathic. Risk factors include autoimmune predisposition, recent infection, and certain systemic conditions.

Diagnosis involves a detailed eye examination, including slit-lamp and dilated fundus examination, supported by imaging (OCT, fluorescein angiography) and laboratory tests to identify infectious etiologies or associated systemic diseases. Prompt recognition and treatment are important to prevent complications.

Treatment is tailored to the type and severity. Anterior uveitis is usually managed with topical corticosteroids and cycloplegic agents, while intermediate, posterior, or panuveitis may require systemic or local immunosuppressants, antiviral or antibacterial therapy if an infection is present, and treatment of any underlying condition. Regular follow-up is essential to monitor response and intraocular pressure.